
El futuro de las vacunaciones contra el COVID-19
Revisado por Dr Krishna Vakharia, MRCGPEscrito por Gillian HarveyPublicado originalmente 3 Apr 2023
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
Desde el inicio de la pandemia de COVID-19, muchas cosas han cambiado en el Reino Unido. El COVID-19 ha mutado y las variantes más recientes están vinculadas con menos hospitalizaciones. Muchos de nosotros hemos recibido ya tres o cuatro vacunas para reducir nuestro riesgo de enfermedad grave por COVID-19, y muchos han sido infectados con el virus y se han recuperado. ¿Qué significa esto para el futuro de las vacunas contra el COVID-19? ¿Y podríamos llegar a un punto en el que las medidas de protección ya no sean necesarias?
A different disease
COVID-19 remains a constantly evolving situation, and nothing is certain. However, using existing data, scientists are now able to predict the most likely outcomes.
COVID-19 isn't likely to disappear anytime soon. But with its effects reduced by a combination of vaccination, immunity from being infected, and the overall less intense symptoms of the Omicron variant1, how we deal with it may change significantly in the future.
Ian Jones, professor of virology from Reading University, explains: "The disease today is very different from how it was when the virus first broke out.
"This is partly because most people now have some immunity from antibodies - disease-fighting proteins developed by our bodies during either vaccination or a previous infection - but also because the current strain of virus is less likely to cause severe disease in the general population."
Vaccination and infection
In the UK, most of us have been vaccinated, have contracted COVID-19, or both2, and therefore are likely to have some residual immunity to the virus. This means that even if we are exposed to COVID-19, we are less likely to contract it than someone with no antibodies and, if we do succumb to infection, are likely to present with milder symptoms.
"The COVID-19 vaccinations haven't been around long enough for us to know how long immunity will last," explains Professor Jones. "There's likely to be a slow decline in protection, but you will probably have some beneficial immunity one or even two years out."
Will we need booster vaccines?
Earlier in the pandemic, healthy members of the public were advised to get vaccinated in order to protect others. However, Professor Jones predicts that future COVID-19 booster jabs are likely to be aimed at the most vulnerable3 - including those over 75, care home residents, and people with compromised immune systems - and offered on a voluntary basis, much like the current vacuna contra la gripe.
"The question of whether you would want to boost existing immunity with an additional vaccine really depends on the strength of the virus and how much it's circulating. There won't be a call for vaccine passports or anything like that - it will be purely voluntary."
An evolving situation
When it comes to science and disease, there are no certainties. However, the fact that viruses do tend to evolve is currently working in our favour with COVID-19, as mutations such as Ómicron have proven less of a risk to our health than previous variants such as Delta. However, it's worth remembering that mutations can also make viruses more dangerous.
In the case of COVID-19, many scientists believe that the virus will continue to weaken. That said, when it comes to disease, things are not always straightforward - there are no guarantees.
The future of the vaccination
In the coming years, the COVID-19 booster is likely to be offered mainly to those who are considered particularly vulnerable to the virus, as is the case with the current flu vaccination.
If COVID-19 continues to weaken, it may be that in future years, vaccination becomes completely unnecessary for all groups.
While it remains important to keep up to date with any developments, when it comes to COVID-19, the future is definitely looking brighter.
Lectura adicional
Selecciones del paciente para Vacunación, pruebas y tratamiento

COVID-19
COVID-19: ¿quién puede hacerse la prueba de coronavirus según la nueva guía del Reino Unido?
The UK government pledged to test 100,000 people per day for coronavirus by the end of April. They managed to squeeze past the finishing line on 30th April and more of us are now eligible for testing than had been previously - so who can get tested?
por Milly Evans

COVID-19
¿Van a cambiar las vacunas durante la pandemia?
Flu season is fast approaching, and the NHS is bracing itself for the usual strain winter ailments place on its services each year. But with the prospect of a second wave of COVID-19 coinciding with these pressures, the government is implementing plans to try to prevent the health service from being stretched to breaking point.
por Allie Anderson
Acerca del revisorVer biografía completa

Dr Krishna Vakharia, MRCGP
Director Médico de Salud, Optum UK
MBChB, MRCGP(2013), BMedSci (hons), DFSRH, DRCOG, PGDipDerm (Distn)
La Dra. Krishna Vakharia es una médica general del NHS. También es examinadora habitual del Diploma de Posgrado en Dermatología Práctica en la Universidad de Cardiff, además de ser la Directora Médica de salud en Optum UK.
Historial del artículo
Artículo también disponible en Inglés, Alemán, Español, Francés, Italiano, Portugués, Hindi, Hebreo, Árabe, y Sueco.
3 Apr 2023 | Publicado originalmente
Escrito por:
Gillian HarveyRevisado por
Dr Krishna Vakharia, MRCGP
Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.


